help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 5, 2005, doi:10.1164/rccm.200502-180OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 3, August 2005, 306-313

A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200502-180OCv1
172/3/306    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comhair, S. A.A.
Right arrow Articles by Severe Asthma Research Program,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comhair, S. A.A.
Right arrow Articles by Severe Asthma Research Program,

Submitted on February 3, 2005
Accepted on April 30, 2005

Correlation of Systemic Superoxide Dismutase Deficiency to Airflow Obstruction in Asthma

Suzy A.A. Comhair1*, Kristin S Ricci1, Mercedes Arroliga2, Abigail R Lara1, Raed A Dweik3, Wei Song4, Stanley L Hazen4, Eugene R Bleecker5, William W Busse5, Kian Fan Chung5, Benjamin Gaston5, Annette Hastie5, Mark Hew5, Nizar Jarjour5, Wendy Moore5, Stephen Peters5, W. Gerald Teague5, Sally E Wenzel5, Serpil C Erzurum3, and Severe Asthma Research Program5

1 Department of Pathobiology, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, 2 Department of Pulmonary, Allergy and Critical Care Medicine, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, 3 Department of Pathobiology, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Pulmonary, Allergy and Critical Care Medicine, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, 4 Department of Cell Biology and Center for Cardiovascular Diagnostics and Prevention, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, 5 The Severe Asthma Research Program (SARP), USA

* To whom correspondence should be addressed. E-mail: comhais{at}ccf.org.

Rationale: Increased oxidative stress and decreased superoxide dismutase (SOD) activity in the asthmatic airway is correlated to airflow limitation and hyperreactivity. We hypothesized that asthmatic individuals with higher levels of oxidative stress may have greater loss of SOD activity, which would be reflected systemically in loss of circulating SOD activity and clinically by development of severe asthma and/or worsening airflow limitation. Methods: To investigate this, serum SOD activity and proteins, glutathione peroxidase/glutathione antioxidant system, and oxidatively modified amino acids were measured in asthmatics and healthy controls. Results: SOD activity, but not MnSOD or CuZnSOD protein, was lower in asthmatic serum as compared to control, and activity loss was significantly related to airflow limitation. Further, serum SOD activity demonstrated an inverse correlation with circulating levels of 3-bromotyrosine, a post-translational modification of proteins produced by the eosinophil peroxidase system of eosinophils. Exposure of purified CuZnSOD to physiologically relevant levels of eosinophil peroxidase-generated reactive brominating species, reactive nitrogen species, or tyrosyl radicals in vitro confirmed that eosinophil-derived oxidative pathways promote enzyme inactivation. Conclusion: These findings are consistent with greater oxidant stress in asthma leading to greater inactivation of SOD, which likely amplifies inflammation and progressive airflow obstruction.


Key words: Asthma, Superoxide dismutase, Antioxidants, GSH




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Lara, S. B. Khatri, Z. Wang, S. A. A. Comhair, W. Xu, R. A. Dweik, M. Bodine, B. S. Levison, J. Hammel, E. Bleecker, et al.
Alterations of the Arginine Metabolome in Asthma
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
A. Nadeem, A. Masood, and N. Siddiqui
Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options
Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS Sleep Tracings Quiz